Lantern Pharma, Inc. (LTRN)
2.05
-0.09
(-4.21%)
USD |
NASDAQ |
May 07, 16:00
2.05
0.00 (0.00%)
After-Hours: 16:59
Lantern Pharma SG&A Expense (TTM) : 6.464M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioVie, Inc. | 8.194M |
| Vertex Pharmaceuticals, Inc. | 1.357B |
| Acurx Pharmaceuticals, Inc. | 6.230M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |